Pharvaris (PHVS) Depreciation and Depletion (2020 - 2026)

Pharvaris has reported Depreciation and Depletion for 7 years, with the latest figure at $122607.5 in Q1 2026.

• For the quarter ending Q1 2026, Depreciation and Depletion rose 10.69% year-over-year to $122607.5; the trailing twelve-month figure through Mar 2026 stood at -$7.7 billion (down 168.31% YoY), and the FY2025 full-year result was $472659.9, up 62.0% from the prior year.
• Depreciation and Depletion for Q1 2026 stood at $122607.5, roughly flat from $122070.9 in the prior quarter.
• The five-year high for Depreciation and Depletion was $235.8 billion in Q2 2025, with the low at -$243.6 billion in Q3 2025.
• Historically, Depreciation and Depletion has averaged -$621.5 million across 5 years, with a median of $71038.9 in 2023.
• The largest YoY upside for Depreciation and Depletion was 356841850.47% in 2023 against a maximum downside of 345944944.87% in 2023.
• Pharvaris' Depreciation and Depletion stood at $47108.9 in 2022, then surged by 50.8% to $71038.9 in 2023, then jumped by 36.82% to $97197.3 in 2024, then grew by 25.59% to $122070.9 in 2025, then climbed by 0.44% to $122607.5 in 2026.
• The last three Depreciation and Depletion figures came in at $122607.5 (Q1 2026), $122070.9 (Q4 2025), and -$243.6 billion (Q3 2025), per Business Quant data.